The POPular TAVI trial has challenged current guideline recommendations on antiplatelet treatment after transcatheter aortic valve implantation (TAVI) in patients…
Lifestyle
Angina drug fails to improve outcomes after successful revascularisation
Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes,…
‘Jumping’ DNA regulates human neurons
The human genome contains over 4.5 million sequences of DNA called “transposable elements,” virus-like entities that “jump” around and help…
For people with high blood pressure, telemonitoring may cut heart attack, stroke rate by 50%
People enrolled in a pharmacist-led telemonitoring program to control high blood pressure were about half as likely to have a…
Large study finds no link between blood pressure medication and cancer
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study…
Body mass index is a more powerful risk factor for diabetes than genetics
Losing weight could prevent or even reverse diabetes, according to late breaking research presented today at ESC Congress 2020. In…
Trial supports first specific treatment for obstructive hypertrophic cardiomyopathy
Mavacamten improves heart function and symptoms in patients with obstructive hypertrophic cardiomyopathy, according to results of the EXPLORER-HCM trial presented…